Skip to content

Efficacy of probiotics for infants with congenital heart disease

Efficacy of probiotics for infants with congenital heart disease - Efficacy of probiotics for infants

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000007143
Enrollment
60
Registered
2012-01-30
Start date
2007-04-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients scheduled for pediatric cardiovascular surgery

Interventions

Sponsors

Department of Anesthesiology, Kyoto prefectural university of medicine
Lead Sponsor
Yakult Honsya Co. Ltd.
Collaborator

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: Infants who will undergo operations at the Department of pediatrics cardiovascular surgery of Kyoto prefectural University of medicine

Exclusion criteria

Exclusion criteria: -A subject whose operation is cancelled. -A subject who is not suitable for the trial defined by the attending researcher.

Design outcomes

Primary

MeasureTime frame
Intestinal microflora Intestinal environment Postoperative complications

Secondary

MeasureTime frame
Length of pediatric intensive care unit Gastrointestinal function

Countries

Japan

Contacts

Public ContactTakako Umenai

Kyoto Prefectural university of medicine Intensive care unit

takako@koto.kpu-m.ac.jp075-251-5633

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026